Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases
Growth differentiation factor 15 (GDF15), a TGF-β superfamily member and stress-responsive cytokine, plays a critical role in metabolism and regulation of inflammation. This review summarizes the expression, distribution, structure, processing, and secretion of GDF15. We also discuss multilayered re...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science (AAAS)
2025-01-01
|
| Series: | Research |
| Online Access: | https://spj.science.org/doi/10.34133/research.0832 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849233686056140800 |
|---|---|
| author | Tian Tian Monan Liu Peter J. Little Hans Strijdom Jianping Weng Suowen Xu |
| author_facet | Tian Tian Monan Liu Peter J. Little Hans Strijdom Jianping Weng Suowen Xu |
| author_sort | Tian Tian |
| collection | DOAJ |
| description | Growth differentiation factor 15 (GDF15), a TGF-β superfamily member and stress-responsive cytokine, plays a critical role in metabolism and regulation of inflammation. This review summarizes the expression, distribution, structure, processing, and secretion of GDF15. We also discuss multilayered regulatory networks governing GDF15 expression, including ATF4/CHOP, AMPK, EGR1, EZH2, PPARγ, NRF2, ERRγ, and p53, as well as posttranscriptional regulator CNOT6L. The GFRAL receptor is central to its function, mediating the anorexigenic and metabolic effects of GDF15. This review synthesizes evidence linking GDF15 to obesity, diabetes, cardiovascular diseases, metabolic liver disorders, cachexia, sarcopenia, and aging while exploring its interactions with key metabolic factors including FGF21, GLP-1, leptin, and glucocorticoids. Lifestyle interventions such as ketogenic, high-fat diets, and exercise modulate GDF15 levels, underscoring its role in pan-metabolic health. Pharmacologically, various agents—including anti-hyperglycemic agents and natural compounds—induce GDF15 expression, implicating their therapeutic potential in cardiometabolic diseases. We comprehensively evaluate current advances in GDF15-targeted drug development, including monoclonal antibodies, fusion proteins, and small-molecule drugs, to provide a scientific foundation for innovative therapies. Finally, we outline unresolved issues in GDF15 biology and therapeutics, such as the exploration of peripheral receptors, contradictory findings in studies of cardiometabolic diseases, and the persistent challenges in developing GDF15-targeted therapeutics. |
| format | Article |
| id | doaj-art-a5338f6ef858445ab93e139269cbf9cd |
| institution | Kabale University |
| issn | 2639-5274 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | American Association for the Advancement of Science (AAAS) |
| record_format | Article |
| series | Research |
| spelling | doaj-art-a5338f6ef858445ab93e139269cbf9cd2025-08-20T04:03:26ZengAmerican Association for the Advancement of Science (AAAS)Research2639-52742025-01-01810.34133/research.0832Emerging Roles of GDF15 in Metabolic and Cardiovascular DiseasesTian Tian0Monan Liu1Peter J. Little2Hans Strijdom3Jianping Weng4Suowen Xu5Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.School of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Woolloongabba, QLD4102, Australia.Centre for Cardio-metabolic Research in Africa, Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.Growth differentiation factor 15 (GDF15), a TGF-β superfamily member and stress-responsive cytokine, plays a critical role in metabolism and regulation of inflammation. This review summarizes the expression, distribution, structure, processing, and secretion of GDF15. We also discuss multilayered regulatory networks governing GDF15 expression, including ATF4/CHOP, AMPK, EGR1, EZH2, PPARγ, NRF2, ERRγ, and p53, as well as posttranscriptional regulator CNOT6L. The GFRAL receptor is central to its function, mediating the anorexigenic and metabolic effects of GDF15. This review synthesizes evidence linking GDF15 to obesity, diabetes, cardiovascular diseases, metabolic liver disorders, cachexia, sarcopenia, and aging while exploring its interactions with key metabolic factors including FGF21, GLP-1, leptin, and glucocorticoids. Lifestyle interventions such as ketogenic, high-fat diets, and exercise modulate GDF15 levels, underscoring its role in pan-metabolic health. Pharmacologically, various agents—including anti-hyperglycemic agents and natural compounds—induce GDF15 expression, implicating their therapeutic potential in cardiometabolic diseases. We comprehensively evaluate current advances in GDF15-targeted drug development, including monoclonal antibodies, fusion proteins, and small-molecule drugs, to provide a scientific foundation for innovative therapies. Finally, we outline unresolved issues in GDF15 biology and therapeutics, such as the exploration of peripheral receptors, contradictory findings in studies of cardiometabolic diseases, and the persistent challenges in developing GDF15-targeted therapeutics.https://spj.science.org/doi/10.34133/research.0832 |
| spellingShingle | Tian Tian Monan Liu Peter J. Little Hans Strijdom Jianping Weng Suowen Xu Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases Research |
| title | Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases |
| title_full | Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases |
| title_fullStr | Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases |
| title_full_unstemmed | Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases |
| title_short | Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases |
| title_sort | emerging roles of gdf15 in metabolic and cardiovascular diseases |
| url | https://spj.science.org/doi/10.34133/research.0832 |
| work_keys_str_mv | AT tiantian emergingrolesofgdf15inmetabolicandcardiovasculardiseases AT monanliu emergingrolesofgdf15inmetabolicandcardiovasculardiseases AT peterjlittle emergingrolesofgdf15inmetabolicandcardiovasculardiseases AT hansstrijdom emergingrolesofgdf15inmetabolicandcardiovasculardiseases AT jianpingweng emergingrolesofgdf15inmetabolicandcardiovasculardiseases AT suowenxu emergingrolesofgdf15inmetabolicandcardiovasculardiseases |